title: Vectorial ligand transport through mammalian choroid plexus.
abstract: In the last decade, there has been substantial progress in understanding vectorial ligand transport through rodent and human choroid plexus (CP), the locus of the blood-CSF interface. In this Review, we enumerate the experimental data required to establish vectorial transport through CP and describe transporters involved in vectorial transport across CP. We also note how these transporters differ from those at the blood-brain barrier. The ligand (substrate) examples presented are methyltetrahydrofolate, methotrexate, leukotriene C(4), nucleosides, thiamine monophosphate, prostaglandins, and digoxin. Our focus is on more definitive experiments, including animal and human transporter "knock-outs." Finally, we discuss the neurochemical implications of vectorial transport through CP and the clinical implications of transporter polymorphisms and knockouts. Examples include descriptions of how vectorial transport through the CP for several micronutrients (e.g., methyltetrahydrofolate) nourishes the brain and how knowledge of CP vectorial transport can lead to important treatments.
authors.affiliation: Department of Medicine, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
authors.forename: Reynold
authors.initials: R
authors.lastname: Spector
authors.forename: Conrad E
authors.initials: CE
authors.lastname: Johanson
mesh_terms: D000818:Animals; D001692:Biological Transport; D001812:Blood-Brain Barrier / Q000378:metabolism*; D002831:Choroid Plexus / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D026901:Membrane Transport Proteins / Q000378:metabolism*; D004364:Pharmaceutical Preparations / Q000097:blood* / Q000134:cerebrospinal fluid*; D013379:Substrate Specificity
chemical_list: D008024:Ligands; D026901:Membrane Transport Proteins; D004364:Pharmaceutical Preparations
references.citation: J Neurochem. 1986 Jun;46(6):1725-31
references.pmid: 3517230
references.citation: Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):283-6
references.pmid: 8990200
references.citation: Neuropediatrics. 1999 Feb;30(1):5-7
references.pmid: 10222453
references.citation: J Histochem Cytochem. 1999 Oct;47(10):1255-64
references.pmid: 10490454
references.citation: J Biol Chem. 2001 Jan 26;276(4):2914-27
references.pmid: 11032837
references.citation: Drug Metab Dispos. 2003 Nov;31(11):1337-45
references.pmid: 14570765
references.citation: Cancer Res. 2002 Jun 1;62(11):3144-50
references.pmid: 12036927
references.citation: Cerebrospinal Fluid Res. 2008 Mar 04;5:5
references.pmid: 18318891
references.citation: Arch Biochem Biophys. 1982 Jul;216(2):693-703
references.pmid: 7114856
references.citation: J Neurochem. 2007 Oct;103(2):425-38
references.pmid: 17645457
references.citation: Am J Hum Genet. 2009 Sep;85(3):354-63
references.pmid: 19732866
references.citation: Biochemistry. 2005 Jan 11;44(1):340-51
references.pmid: 15628876
references.citation: J Appl Physiol (1985). 2006 Apr;100(4):1392-9
references.pmid: 16322371
references.citation: Pflugers Arch. 2001 Nov;443(2):188-95
references.pmid: 11713643
references.citation: Biochim Biophys Acta. 2003 Jan 10;1609(1):1-18
references.pmid: 12507753
references.citation: Pflugers Arch. 2004 Feb;447(5):735-43
references.pmid: 12838422
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9244-9
references.pmid: 12835412
references.citation: Mol Interv. 2009 Jun;9(3):136-45
references.pmid: 19592674
references.citation: J Comp Neurol. 2008 Oct 10;510(5):497-507
references.pmid: 18680196
references.citation: J Neurochem. 2009 Oct;111(2):315-20
references.pmid: 19686385
references.citation: Adv Drug Deliv Rev. 2004 Oct 14;56(12):1765-91
references.pmid: 15381333
references.citation: Mol Cell Biol. 2004 Sep;24(17):7612-21
references.pmid: 15314169
references.citation: Am J Physiol Renal Physiol. 2003 Dec;285(6):F1188-97
references.pmid: 14631946
references.citation: Cancer Treat Rep. 1976 Jul;60(7):913-6
references.pmid: 1009521
references.citation: Biochim Biophys Acta. 1979 Jan 5;550(1):110-9
references.pmid: 216402
references.citation: Am J Physiol Renal Physiol. 2002 May;282(5):F877-85
references.pmid: 11934698
references.citation: Neurochem Res. 1983 Oct;8(10):1307-20
references.pmid: 6656989
references.citation: J Pharmacol Exp Ther. 1974 Jan;188(1):55-65
references.pmid: 4809276
references.citation: Cerebrospinal Fluid Res. 2008 May 14;5:10
references.pmid: 18479516
references.citation: Arch Biochem Biophys. 1981 Apr 15;208(1):87-94
references.pmid: 7259191
references.citation: Biochem Pharmacol. 1986 Sep 1;35(17):2849-53
references.pmid: 3741476
references.citation: Pharm Res. 2007 May;24(5):859-67
references.pmid: 17372683
references.citation: Biochem Biophys Res Commun. 2003 Aug 8;307(4):987-90
references.pmid: 12878209
references.citation: J Clin Invest. 1980 Oct;66(4):821-31
references.pmid: 7419721
references.citation: J Neurochem. 2010 Jan;112(1):13-23
references.pmid: 19860860
references.citation: Science. 1975 Feb 14;187(4176):540-2
references.pmid: 1167256
references.citation: Science. 1995 May 12;268(5212):866-9
references.pmid: 7754369
references.citation: J Clin Invest. 2000 Feb;105(3):279-85
references.pmid: 10675353
references.citation: Trends Pharmacol Sci. 2008 Apr;29(4):200-7
references.pmid: 18353444